Noticias de ARWR_US

Mercado

Noticias del mercado

Últimas noticias sobre ARWR_US — 172 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARWR_US ✕ 172 resultados
29/07/2026 ARWR_US — MarketBeat
Arrowhead Pharmaceuticals, Inc. $ARWR Position Cut by Arrowstreet Capital Limited Partnership
28/07/2026 ARWR_US — Sahm
4 Health Care Stocks With Whale Alerts In Today’s Session
28/07/2026 ARWR_US — biospace.com ES ← EN
Arrowhead Pharmaceuticals completa la inscripción en el estudio global de fase 3 YOSEMITE de Zodasiran para el tratamiento de la hipercolesterolemia familiar homocigótica

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia

27/07/2026 ARWR_US — TradingKey
Arrowhead Pharmaceuticals Inc
27/07/2026 ARWR_US — Yahoo Finance
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
27/07/2026 ARWR_US — MarketBeat
Bank of Nova Scotia Takes $8.53 Million Position in Arrowhead Pharmaceuticals, Inc. $ARWR
27/07/2026 ARWR_US — Business Wire
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
27/07/2026 ARWR_US — Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
27/07/2026 ARWR_US — Stock Titan
BlackRock discloses 10.1% Arrowhead Pharmaceuticals (ARWR) stake in latest 13G/A
27/07/2026 ARWR_US — MarketBeat
1,036,495 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Bought by Renaissance Technologies LLC
27/07/2026 ARWR_US — Stock Titan
Arrowhead's Rare Cholesterol Disease Study Reaches 70 Patients
27/07/2026 ARWR_US — TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings

Página 9 de 9